Protease	O
inhibitors	O
block	O
lipopolysaccharide	O
induction	O
of	O
tissue	O
factor	O
gene	O
expression	O
in	O
human	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
by	O
preventing	O
activation	O
of	O
c-Rel/p65	B-protein
heterodimers	I-protein
.	O

Tissue	B-protein
factor	I-protein
(	O
TF	B-protein
)	O
is	O
expressed	O
rapidly	O
by	O
human	B-cell_type
monocytes	I-cell_type
exposed	O
to	O
bacterial	B-protein
endotoxin	I-protein
(	O
lipopolysaccharide	O
,	O
or	O
LPS	O
)	O
.	O

Transcriptional	O
regulation	O
is	O
mediated	O
by	O
binding	O
of	O
c-Rel/p65	B-protein
heterodimers	I-protein
to	O
a	O
kappa	B-DNA
B-like	I-DNA
site	I-DNA
in	O
the	O
TF	B-DNA
promoter	I-DNA
.	O

Nuclear	O
translocation	O
of	O
cytosolic	B-protein
c-Rel/p65	I-protein
heterodimers	I-protein
and	O
other	O
members	O
of	O
the	O
NF-kappa	B-protein
B/Rel	I-protein
family	I-protein
requires	O
dissociation	O
and	O
proteolytic	O
degradation	O
of	O
the	O
inhibitor	B-protein
protein	I-protein
,	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

The	O
protease	O
inhibitors	O
N	O
alpha-tosylphenylalanyl	O
chloromethyl	O
ketone	O
(	O
TPCK	O
)	O
and	O
N	O
alpha-tosyl-L-lysine	O
chloromethyl	O
ketone	O
(	O
TLCK	O
)	O
block	O
activation	O
of	O
NF-kappa	B-protein
B/Rel	I-protein
proteins	I-protein
by	O
preventing	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

To	O
determine	O
if	O
TPCK	O
and	O
TLCK	O
inhibited	O
LPS	O
induction	O
of	O
TF	B-protein
expression	O
,	O
freshly	O
isolated	O
human	B-cell_type
monocytes	I-cell_type
and	O
monocytic	B-cell_line
THP-1	I-cell_line
cells	I-cell_line
were	O
pretreated	O
with	O
these	O
inhibitors	O
for	O
30	O
min	O
before	O
LPS	O
stimulation	O
.	O

Both	O
TPCK	O
and	O
TLCK	O
inhibited	O
LPS	O
induction	O
of	O
TF	B-protein
protein	I-protein
,	O
TF	B-RNA
mRNA	I-RNA
and	O
TF	B-protein
promoter	O
activity	O
in	O
a	O
dose-dependent	O
manner	O
.	O

These	O
inhibitors	O
specifically	O
prevented	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
and	O
nuclear	O
translocation	O
of	O
c-Rel/p65	B-protein
heterodimers	I-protein
.	O

In	O
contrast	O
,	O
TPCK	O
and	O
TLCK	O
did	O
not	O
block	O
induction	O
of	O
an	O
immediate-early	B-DNA
gene	I-DNA
encoding	O
the	O
transcription	B-protein
factor	I-protein
,	O
Egr-1	B-protein
.	O

Taken	O
together	O
,	O
these	O
data	O
indicated	O
that	O
inhibiting	O
nuclear	O
translocation	O
of	O
c-Rel/p65	B-protein
heterodimers	I-protein
prevented	O
LPS	O
induction	O
of	O
TF	B-protein
gene	O
transcription	O
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

THs	NULL
Journat	NULL
or	NULL
Brovocicat	NULL
Cremstry	NULL
.	NULL

©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

42	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
21	NULL
,	NULL
pp	NULL
.	NULL

26363~26367	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Protease	NULL
Inhibitors	NULL
Block	NULL
Lipopolysaccharide	NULL
Induction	NULL
of	NULL
Tissue	NULL
Factor	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytic	NULL
Cells	NULL
by	NULL
Preventing	NULL
Activation	NULL
of	NULL
c-ReV/p65	NULL
Heterodimers*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
27	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
29	NULL
,	NULL
1994	NULL
)	NULL
Nige	NULL
!	NULL

Mackmant	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
Tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
is	NULL
expressed	NULL
rapidly	NULL
by	NULL
human	NULL
monocytes	NULL
exposed	NULL
to	NULL
bacterial	NULL
endotoxin	NULL
(	NULL
lipopolysac-charide	NULL
,	NULL
or	NULL
LPS	NULL
)	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
a	NULL
«	NULL
B-like	NULL
site	NULL
in	NULL
the	NULL
TF	NULL
promoter	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
cytosolic	NULL
c-Rel/p65	NULL
heterodimers	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
requires	NULL
dissociation	NULL
and	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
protein	NULL
,	NULL
IxBa	NULL
.	NULL

The	NULL
protease	NULL
inhibitors	NULL
N*tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
and	NULL
N®-tosyl-v-lysine	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
)	NULL
block	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
by	NULL
preventing	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
TPCK	NULL
and	NULL
TLCK	NULL
inhibited	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
,	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
and	NULL
monocytic	NULL
THP	NULL
-1	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
these	NULL
inhibitors	NULL
for	NULL
30	NULL
min	NULL
before	NULL
LPS	NULL
stimulation	NULL
.	NULL

Both	NULL
TPCK	NULL
and	NULL
TLCK	NULL
inhibited	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
protein	NULL
,	NULL
TF	NULL
mRNA	NULL
and	NULL
TF	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

These	NULL
inhibitors	NULL
specifically	NULL
prevented	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TPCK	NULL
and	NULL
TLCK	NULL
did	NULL
not	NULL
block	NULL
induction	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
encoding	NULL
the	NULL
transcription	NULL
fac-tor	NULL
,	NULL
Egr-1	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicated	NULL
that	NULL
inhibiting	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
prevented	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Exposure	NULL
of	NULL
monocytes	NULL
to	NULL
bacterial	NULL
endotoxin	NULL
(	NULL
lipopolysac-charide	NULL
,	NULL
or	NULL
LPS	NULL
]	NULL
induces	NULL
cell-surface	NULL
expression	NULL
of	NULL
tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
procoagulant	NULL
molecule	NULL
that	NULL
triggers	NULL
the	NULL
coagulation	NULL
protease	NULL
cascades	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Monocytes	NULL
may	NULL
be	NULL
the	NULL
primary	NULL
source	NULL
of	NULL
TF	NULL
expression	NULL
in	NULL
animal	NULL
models	NULL
of	NULL
sepsis	NULL
(	NULL
2-4	NULL
)	NULL
and	NULL
in	NULL
patients	NULL
with	NULL
septicemia	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
studies	NULL
using	NULL
chimpanzees	NULL
indicate	NULL
that	NULL
administration	NULL
of	NULL
pentoxifylline	NULL
,	NULL
an	NULL
agent	NULL
that	NULL
inhibits	NULL
gene	NULL
activation	NULL
in	NULL
monocytes	NULL
,	NULL
markedly	NULL
inhibits	NULL
endotoxin-induced	NULL
activation	NULL
of	NULL
coagulation	NULL
(	NULL
4	NULL
)	NULL
,	NULL
presumably	NULL
by	NULL
reducing	NULL
monocyte	NULL
TF	NULL
expression	NULL
.	NULL

TF	NULL
is	NULL
rapidly	NULL
and	NULL
transiently	NULL
expressed	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

This	NULL
induction	NULL
is	NULL
inhibited	NULL
by	NULL
agents	NULL
that	NULL
elevate	NULL
intracellular	NULL
levels	NULL
of	NULL
cyclic	NULL
*	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
HL-48872	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
10666	NULL
N.	NULL
Torrey	NULL
Pines	NULL
Rd	NULL
.	NULL

,	NULL
IMM-17	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
619-554-8594	NULL
;	NULL
Fax	NULL
:	NULL
619-554-6146	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
bacterial	NULL
en-dotoxin	NULL
)	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
;	NULL
LUC	NULL
,	NULL
luciferase	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
TLCK	NULL
,	NULL
N°	NULL
tosyl-u-lysine	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
TPCK	NULL
,	NULL
N®-tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
;	NULL
TF	NULL
,	NULL
tissue	NULL
factor	NULL
;	NULL
FITC	NULL
,	NULL
fluorescein	NULL
isothiocyanate	NULL
.	NULL

AMP	NULL
,	NULL
including	NULL
dibutyryl	NULL
cAMP	NULL
and	NULL
pentoxifylline	NULL
(	NULL
8-12	NULL
)	NULL
,	NULL
and	NULL
the	NULL
immunosuppressive	NULL
cytokines	NULL
interleukin	NULL
4	NULL
and	NULL
interlenu-kin	NULL
10	NULL
(	NULL
13-17	NULL
)	NULL
,	NULL
although	NULL
the	NULL
mechanisms	NULL
of	NULL
inhibition	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
established	NULL
.	NULL

Regulation	NULL
of	NULL
TF	NULL
expression	NULL
is	NULL
controlled	NULL
primarily	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Functional	NULL
studies	NULL
in	NULL
our	NULL
laboratory	NULL
using	NULL
THP-1	NULL
cells	NULL
indicate	NULL
that	NULL
a	NULL
decameric	NULL
xB-like	NULL
site	NULL
in	NULL
the	NULL
human	NULL
TF	NULL
promoter	NULL
mediates	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
this	NULL
xB-like	NULL
site	NULL
exclusively	NULL
binds	NULL
c-Rel/p65	NULL
heterodimers	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
and	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
LPS-mediated	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
and	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B-like	NULL
site	NULL
in	NULL
the	NULL
TF	NULL
promoter	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factor	NULL
family	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
many	NULL
genes	NULL
expressed	NULL
by	NULL
activated	NULL
monocytes	NULL
{	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
requires	NULL
dissociation	NULL
of	NULL
inhibitor	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
IxBa	NULL
,	NULL
before	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
,	NULL
LPS-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
is	NULL
achieved	NULL
through	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
indicate	NULL
that	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
also	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
23	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
show	NULL
that	NULL
the	NULL
protease	NULL
inhibitor	NULL
N*-tosylphenylalanyl	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
chymotrypsin-like	NULL
serine	NULL
proteases	NULL
,	NULL
and	NULL
the	NULL
structurally	NULL
related	NULL
inhibitor	NULL
N*-tosyl-L-lysine	NULL
chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
)	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
trypsin-like	NULL
serine	NULL
proteases	NULL
,	NULL
prevent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
LPS	NULL
,	NULL
interleukin	NULL
18	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
I	NULL
demonstrated	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
was	NULL
abolished	NULL
by	NULL
pretreating	NULL
cells	NULL
with	NULL
the	NULL
protease	NULL
inhibitors	NULL
TPCK	NULL
and	NULL
TLCK	NULL
.	NULL

Inhibition	NULL
was	NULL
dose-dependent	NULL
,	NULL
although	NULL
TPCK	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
than	NULL
TLCK	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
indicated	NULL
that	NULL
both	NULL
agents	NULL
inhibited	NULL
the	NULL
LPS-induced	NULL
loss	NULL
of	NULL
IxBa	NULL
protein	NULL
and	NULL
thus	NULL
prevented	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
,	NULL
consistent	NULL
with	NULL
this	NULL
transcription	NULL
factor	NULL
acting	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
TF	NULL
gene	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
serotype	NULL
O111	NULL
:	NULL
B4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
protease	NULL
inhibitors	NULL
TPCK	NULL
and	NULL
TLCK	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
.	NULL

Phor-boi	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

A	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
conjugate	NULL
of	NULL
MY4	NULL
(	NULL
MY4-FITC	NULL
)	NULL
,	NULL
a	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
human	NULL
CD14	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Coulter	NULL
Immunology	NULL
(	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

A	NULL
FITC-labeled	NULL
anti-human	NULL
TF	NULL
antibody	NULL
,	NULL
TF8-5G9	NULL
(	NULL
24	NULL
)	NULL
,	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
T.	NULL
S.	NULL
Edgington	NULL
(	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
)	NULL
.	NULL

Monocyte	NULL
Isolation	NULL
and	NULL
Cell	NULL
Culture-Heparinized	NULL
blood	NULL
was	NULL
drawn	NULL
from	NULL
volunteers	NULL
,	NULL
and	NULL
plasma	NULL
was	NULL
removed	NULL
following	NULL
centrifugation	NULL
at	NULL
200	NULL
x	NULL
g.	NULL
Blood	NULL
cells	NULL
were	NULL
diluted	NULL
1:1	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Inc.	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
overlaid	NULL
onto	NULL
Ficoll-Hypaque	NULL
(	NULL
Phar-macia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Following	NULL
centrifugation	NULL
at	NULL
400	NULL
x	NULL
g	NULL
,	NULL
the	NULL
pe-	NULL
26363	NULL
26364	NULL
ripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
removed	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
medium	NULL
,	NULL
Further	NULL
purification	NULL
of	NULL
monocytes	NULL
was	NULL
performed	NULL
using	NULL
Sepracell-MN	NULL
(	NULL
Sepratech	NULL
,	NULL
Oklahoma	NULL
City	NULL
,	NULL
OK	NULL
)	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
>	NULL
75	NULL
%	NULL
monocytes	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
employing	NULL
the	NULL
anti-CD14	NULL
antibody	NULL
,	NULL
MY4-FITC	NULL
.	NULL

Human	NULL
monocytic	NULL
leukemia	NULL
THP-1	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
cultivated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2-5	NULL
x	NULL
10°	NULL
cells/ml	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

All	NULL
reagents	NULL
were	NULL
tested	NULL
by	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
contained	NULL
<	NULL
5	NULL
pg/ml	NULL
endotoxin	NULL
contamination	NULL
.	NULL

FACS	NULL
Analysis	NULL
of	NULL
TF	NULL
Antigen	NULL
Expression-PBMC	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
5	NULL
h	NULL
with	NULL
LPS	NULL
before	NULL
incubating	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
anti-human	NULL
TF-FITC	NULL
or	NULL
MY4-FITC	NULL
antibodies	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
fixed	NULL
in	NULL
0.5	NULL
%	NULL
paraformaldehyde	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Live	NULL
gating	NULL
on	NULL
the	NULL
monocyte	NULL
population	NULL
was	NULL
accomplished	NULL
using	NULL
near	NULL
forward	NULL
angle	NULL
and	NULL
orthogonal	NULL
light	NULL
scatter	NULL
as	NULL
well	NULL
as	NULL
staining	NULL
with	NULL
MY4-FITC	NULL
antibody	NULL
.	NULL

TF	NULL
Activity-Cell	NULL
pellets	NULL
were	NULL
solubilized	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
15	NULL
min	NULL
using	NULL
15	NULL
mm	NULL
octyl	NULL
B-p-glucopyranoside	NULL
.	NULL

TF	NULL
activity	NULL
was	NULL
assayed	NULL
in	NULL
cell	NULL
lysates	NULL
using	NULL
a	NULL
one-stage	NULL
clotting	NULL
assay	NULL
as	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Clotting	NULL
times	NULL
were	NULL
converted	NULL
to	NULL
milliunits	NULL
of	NULL
TF	NULL
activity	NULL
by	NULL
comparison	NULL
to	NULL
a	NULL
standard	NULL
curve	NULL
established	NULL
with	NULL
purified	NULL
human	NULL
brain	NULL
TF	NULL
(	NULL
24	NULL
)	NULL
.	NULL

For	NULL
reference	NULL
,	NULL
a	NULL
clotting	NULL
time	NULL
of	NULL
50	NULL
s	NULL
corresponds	NULL
to	NULL
1,000	NULL
milliunits	NULL
of	NULL
TF	NULL
activity	NULL
.	NULL

Analysis	NULL
of	NULL
TF	NULL
mRNA-Total	NULL
cellular	NULL
RNA	NULL
,	NULL
purified	NULL
using	NULL
guanidine	NULL
thiocyanate-CsC1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

A	NULL
641-base	NULL
pair	NULL
human	NULL
TF	NULL
cDNA	NULL
fragment	NULL
(	NULL
27	NULL
)	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
a-P	NULL
]	NULL
dCTP	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
and	NULL
used	NULL
to	NULL
determine	NULL
TF	NULL
mRNA	NULL
levels	NULL
.	NULL

Blots	NULL
were	NULL
rehybridized	NULL
with	NULL
a	NULL
housekeeping	NULL
gene	NULL
,	NULL
glucose-6-phosphate	NULL
dehydrogenase	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
-70	NULL
°C	NULL
,	NULL
employing	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

Plasmids	NULL
and	NULL
Transfections-pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
contains	NULL
278	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
human	NULL
TF	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
(	NULL
LUC	NULL
)	NULL
reporter	NULL
(	NULL
18	NULL
)	NULL
.	NULL

p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
contains	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
TF	NULL
«	NULL
B-like	NULL
site	NULL
(	NULL
TF	NULL
)	NULL
inserted	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
SV40	NULL
promoter	NULL
expressing	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
18	NULL
)	NULL
and	NULL
cultivated	NULL
for	NULL
46	NULL
h	NULL
before	NULL
a	NULL
5	NULL
h	NULL
stimulation	NULL
with	NULL
LPS	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Luciferase	NULL
Assay	NULL
System	NULL
(	NULL
Promega	NULL
Corp.	NULL
)	NULL
and	NULL
a	NULL
Monolight	NULL
2010	NULL
lumi-nometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

2	NULL
ug	NULL
of	NULL
pCMV	NULL
$	NULL
B	NULL
(	NULL
Clontech	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
to	NULL
assess	NULL
transfection	NULL
efficiencies	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
expressed	NULL
by	NULL
pCMVB	NULL
was	NULL
assayed	NULL
using	NULL
Galacto-light	NULL
(	NULL
Tropix	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
exhibited	NULL
less	NULL
than	NULL
a	NULL
10	NULL
%	NULL
variation	NULL
between	NULL
samples	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Nuclear	NULL
and	NULL
cytosolic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
5	NULL
x	NULL
10°	NULL
monocytes	NULL
or	NULL
THP-1	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
19	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
these	NULL
extracts	NULL
were	NULL
1-5	NULL
mg/	NULL
ml	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
BCA	NULL
protein	NULL
assay	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
(	NULL
Operon	NULL
Technologies	NULL
Inc.	NULL
,	NULL
Alameda	NULL
,	NULL
CA	NULL
)	NULL
containing	NULL
the	NULL
TF	NULL
xB-like	NULL
site	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
5-GTCCCGGAGTTTCCTACCGGG-3	NULL
,	NULL
was	NULL
annealed	NULL
with	NULL
a	NULL
primer	NULL
and	NULL
radiolabeled	NULL
using	NULL
[	NULL
«	NULL
-PIdCTP	NULL
(	NULL
>	NULL
3000	NULL
Ci/mmol	NULL
,	NULL
Amersham	NULL
Corp.	NULL
)	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
binding	NULL
of	NULL
EGR-1	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
prototypic	NULL
EGR-1	NULL
site	NULL
,	NULL
5-AGTCGGGAGGAGCGGCGGGGGCGGGCGCCGG-3	NULL
'	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
DNA	NULL
probe	NULL
by	NULL
electrophoresis	NULL
through	NULL
6	NULL
%	NULL
non-denaturing	NULL
acrylamide	NULL
gets	NULL
(	NULL
Novex	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
in	NULL
0.5	NULL
x	NULL
Tris	NULL
borate-EDTA	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-THP-1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
various	NULL
times	NULL
and	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
as	NULL
above	NULL
.	NULL

Extracts	NULL
were	NULL
electrophoresed	NULL
on	NULL
8-16	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
(	NULL
Novex	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
Hybond-ECL	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Immuno-reactive	NULL
proteins	NULL
were	NULL
detected	NULL
according	NULL
to	NULL
the	NULL
ECL	NULL
protocol	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
using	NULL
a	NULL
1:2500	NULL
dilution	NULL
of	NULL
an	NULL
IxBa	NULL
antiserum	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Antibodies-IxBa	NULL
antiserum	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

Antisera	NULL
against	NULL
EGR-1	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
AP-2	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnolgy	NULL
.	NULL

RESULTS	NULL
Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytic	NULL
Cells-Recently	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
activation	NULL
of	NULL
c-Rel/	NULL
p65	NULL
heterodimers	NULL
is	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
(	NULL
19	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
agents	NULL
capable	NULL
of	NULL
preventing	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
the	NULL
protease	NULL
inhibitor	NULL
TPCK	NULL
,	NULL
could	NULL
inhibit	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
protease	NULL
inhibitors	NULL
Inhibition	NULL
of	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
Control	NULL
(	NULL
MCF	NULL
=	NULL
15	NULL
)	NULL
30	NULL
30	NULL
LPS	NULL
(	NULL
MCF	NULL
=	NULL
50	NULL
)	NULL
o	NULL
sar	NULL
a	NULL
108	NULL
104	NULL
10°	NULL
10	NULL
}	NULL
[	NULL
Aol	NULL
90°	NULL
10	NULL
)	NULL
10°	NULL
e	NULL
a	NULL
s	NULL
TPCK+LPS	NULL
(	NULL
MCF	NULL
=	NULL
19	NULL
)	NULL
30	NULL
30	NULL
TLCK+LPS	NULL
(	NULL
MCF	NULL
=	NULL
57	NULL
)	NULL
Cell	NULL
Number	NULL
--	NULL
-	NULL
»	NULL
QB	NULL
“	NULL
10°	NULL
10	NULL
104	NULL
10°	NULL
$	NULL
00	NULL
10	NULL
}	NULL
108	NULL
104	NULL
102	NULL
Fluorescence	NULL
Intensity	NULL
--	NULL
-	NULL
»	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
antigen	NULL
expression	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

PBMC	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
5	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
pum	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
uw	NULL
)	NULL
.	NULL

The	NULL
control	NULL
sample	NULL
is	NULL
PBMC	NULL
incubated	NULL
for	NULL
5	NULL
h	NULL
without	NULL
LPS	NULL
or	NULL
protease	NULL
inhibitors	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
FITC-labeled	NULL
human	NULL
TF-specific	NULL
monoclonal	NULL
antibody	NULL
,	NULL
TFS8-5G9	NULL
.	NULL

Expression	NULL
of	NULL
TF	NULL
antigen	NULL
was	NULL
determined	NULL
by	NULL
FACS	NULL
using	NULL
live	NULL
gating	NULL
to	NULL
analyze	NULL
the	NULL
monocyte	NULL
population	NULL
.	NULL

Results	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
expressed	NULL
as	NULL
log	NULL
fluorescence	NULL
intensity	NULL
versus	NULL
cell	NULL
number	NULL
.	NULL

Mean	NULL
channel	NULL
fluorescence	NULL
(	NULL
MCF	NULL
)	NULL
for	NULL
each	NULL
sample	NULL
is	NULL
shown	NULL
.	NULL

blocked	NULL
LPS-induced	NULL
TF	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
TF	NULL
antigen	NULL
expression	NULL
was	NULL
measured	NULL
in	NULL
PBMC	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
5	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
either	NULL
TPCK	NULL
or	NULL
the	NULL
structurally	NULL
related	NULL
protease	NULL
inhibitor	NULL
,	NULL
TLCK	NULL
.	NULL

LPS	NULL
induction	NULL
of	NULL
TF	NULL
antigen	NULL
expression	NULL
by	NULL
PBMC	NULL
,	NULL
measured	NULL
by	NULL
FACS	NULL
analysis	NULL
,	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
but	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
the	NULL
less	NULL
potent	NULL
inhibitor	NULL
TLCK	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
activity	NULL
expressed	NULL
by	NULL
PBMC	NULL
and	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
,	NULL
measured	NULL
using	NULL
a	NULL
one-stage	NULL
clotting	NULL
assay	NULL
,	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
and	NULL
only	NULL
slightly	NULL
reduced	NULL
by	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
level	NULL
of	NULL
TF	NULL
activity	NULL
expressed	NULL
by	NULL
untreated	NULL
PBMC	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
,	NULL
C	NULL
)	NULL
was	NULL
reduced	NULL
by	NULL
simultaneous	NULL
exposure	NULL
to	NULL
TPCK	NULL
and	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
TPCK	NULL
was	NULL
not	NULL
a	NULL
result	NULL
of	NULL
inhibition	NULL
of	NULL
procoagulant	NULL
activity	NULL
in	NULL
the	NULL
one-stage	NULL
clotting	NULL
assay	NULL
because	NULL
this	NULL
inhibitor	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
clotting	NULL
times	NULL
when	NULL
added	NULL
to	NULL
cells	NULL
immediately	NULL
before	NULL
harvest	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TPCK	NULL
did	NULL
not	NULL
reduce	NULL
cell	NULL
viability	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Dose	NULL
titrations	NULL
were	NULL
performed	NULL
using	NULL
these	NULL
inhibitors	NULL
because	NULL
previous	NULL
studies	NULL
indicated	NULL
that	NULL
TPCK	NULL
inhibits	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
more	NULL
effectively	NULL
than	NULL
TLCK	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
TPCK	NULL
(	NULL
0.1-2.5	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10-100	NULL
um	NULL
)	NULL
led	NULL
to	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
activity	NULL
in	NULL
PBMC	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

Induced	NULL
TF	NULL
activity	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
1	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
TPCK	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
than	NULL
TLCK	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
mRNA	NULL
Expression-To	NULL
determine	NULL
if	NULL
TPCK	NULL
inhibited	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
mRNA	NULL
,	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
this	NULL
protease	NULL
inhibitor	NULL
.	NULL

Induction	NULL
of	NULL
TF	NULL
mRNA	NULL
was	NULL
inhibited	NULL
79	NULL
%	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
TLCK	NULL
led	NULL
to	NULL
only	NULL
a	NULL
22	NULL
%	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
at	NULL
4	NULL
h	NULL
and	NULL
TF	NULL
mRNA	NULL
levels	NULL
declined	NULL
to	NULL
base-line	NULL
level	NULL
at	NULL
6	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
abolished	NULL
induction	NULL
of	NULL
TF	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TPCK	NULL
inhibited	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
mRNA	NULL
in	NULL
Inhibition	NULL
of	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
a	NULL
PBMC	NULL
THP	NULL
12	NULL
6	NULL
10	NULL
5	NULL
C	NULL
6	NULL
2	NULL
s	NULL
5	NULL
&	NULL
a	NULL
6	NULL
2	NULL
8	NULL
3	NULL
g	NULL
0	NULL
2	NULL
9	NULL
5	NULL
%	NULL
®	NULL
§	NULL
¢	NULL
:	NULL
*	NULL
IK	NULL
3	NULL
-	NULL
A	NULL
m	NULL
|-i2	NULL
6	NULL
T	NULL
s	NULL
*	NULL
2	NULL
1	NULL
o	NULL
C	NULL
LPS	NULL
TPCK	NULL
TLCK	NULL
C	NULL
LPS	NULL
TPCK	NULL
TLCK	NULL
+	NULL
+	NULL
+	NULL
+	NULL
LPS	NULL
LPS	NULL
LPS	NULL
LPS	NULL
Fold	NULL
Induction	NULL
of	NULL
TF	NULL
Activity	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
[	NULL
01	NULL
05	NULL
1.0	NULL
25	NULL
,	NULL
10	NULL
25	NULL
50	NULL
100	NULL
,	NULL
TPCK	NULL
(	NULL
M	NULL
)	NULL
TLCK	NULL
(	NULL
@	NULL
M	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
activity	NULL
expressed	NULL
by	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Panel	NULL
a	NULL
,	NULL
PBMC	NULL
and	NULL
THP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
1	NULL
and	NULL
10	NULL
ug/ml	NULL
LPS	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
5	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
.	NULL

Control	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
5	NULL
h	NULL
without	NULL
LPS	NULL
or	NULL
protease	NULL
inhibitors	NULL
.	NULL

TF	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
one-stage	NULL
clotting	NULL
assay	NULL
.	NULL

Mean	NULL
-fold	NULL
induction	NULL
+	NULL
standard	NULL
deviation	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
level	NULL
of	NULL
TF	NULL
activity	NULL
expressed	NULL
by	NULL
uninduced	NULL
PBMC	NULL
and	NULL
THP-1	NULL
cells	NULL
was	NULL
285	NULL
+	NULL
69	NULL
milliunits/10®	NULL
cells	NULL
and	NULL
184	NULL
+	NULL
14	NULL
milliunits/10®	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Panel	NULL
b	NULL
,	NULL
PBMC	NULL
were	NULL
incubated	NULL
with	NULL
TPCK	NULL
(	NULL
0.1	NULL
,	NULL
0.5	NULL
,	NULL
1.0	NULL
,	NULL
and	NULL
2.5	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
and	NULL
100	NULL
um	NULL
)	NULL
for	NULL
30	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
5	NULL
h.	NULL
TF	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
above	NULL
.	NULL

monocytic	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
Gene	NULL
Transcription-To	NULL
determine	NULL
if	NULL
TPCK	NULL
blocked	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
transcription	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
human	NULL
TF	NULL
promoter	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
10	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
for	NULL
5	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
or	NULL
TLCK	NULL
.	NULL

Induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
,	NULL
which	NULL
contains	NULL
278	NULL
base	NULL
pairs	NULL
of	NULL
the	NULL
TF	NULL
promoter	NULL
including	NULL
the	NULL
«	NULL
B-like	NULL
site	NULL
at	NULL
-179	NULL
,	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
and	NULL
slightly	NULL
reduced	NULL
by	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Further	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
,	NULL
a	NULL
plasmid	NULL
that	NULL
contains	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
TF	NULL
«	NULL
B-like	NULL
site	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
and	NULL
unaffected	NULL
by	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TPCK	NULL
and	NULL
TLCK	NULL
reduced	NULL
LPS	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
abolishing	NULL
induction	NULL
at	NULL
doses	NULL
of	NULL
5	NULL
and	NULL
100	NULL
um	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

LPS	NULL
Activation	NULL
of	NULL
c-Rel	NULL
/p65	NULL
Heterodimers	NULL
Was	NULL
Inhibited	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK-To	NULL
determine	NULL
if	NULL
TPCK	NULL
acted	NULL
by	NULL
preventing	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
26365	NULL
TPCK	NULL
(	NULL
10uM	NULL
)	NULL
-	NULL
-	NULL
-+	NULL
TLCK	NULL
(	NULL
10uM	NULL
)	NULL
-	NULL
LPS	NULL
-	NULL
+	NULL
TF	NULL
mRNA	NULL
»	NULL
’	NULL
G6PDH	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
mRNA	NULL
expression	NULL
by	NULL
THP-1	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
pum	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
.	NULL

The	NULL
control	NULL
sample	NULL
was	NULL
incubated	NULL
without	NULL
LPS	NULL
and	NULL
protease	NULL
inhibitors	NULL
.	NULL

TF	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
radiolabeled	NULL
human	NULL
TF	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
reprobed	NULL
to	NULL
determine	NULL
glucose-6-phosphate	NULL
dehydrogenase	NULL
(	NULL
GSPDH	NULL
)	NULL
mRNA	NULL
levels	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
TF	NULL
mRNA	NULL
is	NULL
indicated	NULL
.	NULL

Band	NULL
intensities	NULL
were	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
using	NULL
a	NULL
Personal	NULL
Densitometer	NULL
and	NULL
ImageQuant	NULL
software	NULL
(	NULL
Mo-lecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
following	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
TF	NULL
mRNA	NULL
levels	NULL
:	NULL
control	NULL
,	NULL
100	NULL
;	NULL
LPS	NULL
,	NULL
2663	NULL
;	NULL
TLCK	NULL
+	NULL
LPS	NULL
,	NULL
2693	NULL
;	NULL
TPCK	NULL
+	NULL
LPS	NULL
,	NULL
574	NULL
;	NULL
and	NULL
for	NULL
glucose-6-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
levels	NULL
:	NULL
control	NULL
,	NULL
847	NULL
;	NULL
LPS	NULL
,	NULL
1165	NULL
;	NULL
TLCK	NULL
+	NULL
LPS	NULL
,	NULL
1502	NULL
;	NULL
TPCK	NULL
+	NULL
LPS	NULL
,	NULL
1198	NULL
.	NULL

The	NULL
percentage	NULL
inhibition	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
discussed	NULL
in	NULL
the	NULL
text	NULL
was	NULL
calculated	NULL
using	NULL
TF	NULL
mRNA	NULL
levels	NULL
normalized	NULL
against	NULL
glucose-6-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
levels	NULL
.	NULL

or	NULL
THP	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
.	NULL

DNA	NULL
binding	NULL
proteins	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
TF	NULL
«	NULL
B-like	NULL
site	NULL
(	NULL
19	NULL
)	NULL
.	NULL

LPS	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
was	NULL
abolished	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
and	NULL
slightly	NULL
reduced	NULL
by	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5a	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
complex	NULL
observed	NULL
in	NULL
all	NULL
lanes	NULL
represents	NULL
binding	NULL
of	NULL
nonspecific	NULL
protein	NULL
(	NULL
19	NULL
)	NULL
.	NULL

LPS	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
THP-1	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

TPCK	NULL
(	NULL
5	NULL
um	NULL
)	NULL
completely	NULL
abolished	NULL
c-Rel/p65	NULL
activation	NULL
,	NULL
whereas	NULL
a	NULL
20	NULL
times	NULL
higher	NULL
concentration	NULL
of	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
was	NULL
required	NULL
to	NULL
achieve	NULL
a	NULL
similar	NULL
level	NULL
of	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
.	NULL

LPS	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
)	NULL
in	NULL
THP	NULL
cells	NULL
also	NULL
was	NULL
inhibited	NULL
by	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
and	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
strongly	NULL
suggest	NULL
that	NULL
TPCK	NULL
and	NULL
TLCK	NULL
inhibit	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
by	NULL
preventing	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
LPS	NULL
activation	NULL
of	NULL
THP-1	NULL
cells	NULL
results	NULL
in	NULL
a	NULL
transient	NULL
reduction	NULL
of	NULL
IxBa	NULL
protein	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
TPCK	NULL
and	NULL
TLCK	NULL
acted	NULL
by	NULL
stabilizing	NULL
IxBa	NULL
protein	NULL
in	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
,	NULL
IxBa	NULL
protein	NULL
was	NULL
monitored	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

A	NULL
30-min	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
TPCK	NULL
(	NULL
5	NULL
or	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
abolished	NULL
this	NULL
transient	NULL
reduction	NULL
in	NULL
I	NULL
«	NULL
kBa	NULL
protein	NULL
,	NULL
whereas	NULL
lower	NULL
concentrations	NULL
of	NULL
TPCK	NULL
(	NULL
1	NULL
um	NULL
)	NULL
and	NULL
TLCK	NULL
(	NULL
10	NULL
un	NULL
)	NULL
failed	NULL
to	NULL
prevent	NULL
loss	NULL
of	NULL
IxBa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5b	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
protease	NULL
inhibitors	NULL
stabilized	NULL
IxBa	NULL
protein	NULL
in	NULL
LPS-stimulated	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
EGR-1	NULL
in	NULL
Monocytic	NULL
Cells	NULL
Was	NULL
Not	NULL
Inhibited	NULL
by	NULL
Protease	NULL
Inhibitors-To	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
inhibition	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
,	NULL
induction	NULL
of	NULL
the	NULL
immediate-early	NULL
gene	NULL
,	NULL
egr-1	NULL
,	NULL
was	NULL
examined	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
these	NULL
protease	NULL
inhibitors	NULL
at	NULL
concentrations	NULL
that	NULL
completely	NULL
blocked	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
and	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
.	NULL

Previous	NULL
studies	NULL
indicated	NULL
that	NULL
egr-1	NULL
gene	NULL
expression	NULL
is	NULL
induced	NULL
in	NULL
monocytic	NULL
cells	NULL
exposed	NULL
to	NULL
phorbol	NULL
esters	NULL
(	NULL
29	NULL
)	NULL
.	NULL

This	NULL
26366	NULL
a	NULL
-	NULL
12	NULL
100	NULL
FA	NULL
10f	NULL
‘	NULL
7	NULL
2	NULL
80	NULL
c	NULL
3	NULL
.	NULL

>	NULL
58	NULL
s	NULL
}	NULL
|	NULL
58	NULL
6	NULL
0	NULL
C	NULL
60	NULL
O	NULL
8	NULL
3	NULL
8	NULL
E8	NULL
6	NULL
€	NULL
8	NULL
2	NULL
$	NULL
,	NULL
z	NULL
{	NULL
2	NULL
3	NULL
2	NULL
3	NULL
6	NULL
>	NULL
x	NULL
20	NULL
0	NULL
0	NULL
C	NULL
LPS	NULL
TPCK	NULL
TLCK	NULL
C	NULL
LPS	NULL
TPCK	NULL
TLCK	NULL
+	NULL
+	NULL
+	NULL
+	NULL
LPS	NULL
LPS	NULL
LPS	NULL
LPS	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
y-	NULL
Pn	NULL
o	NULL
£	NULL
2	NULL
|	NULL
5	NULL
6	NULL
3	NULL
<	NULL
I	NULL
3	NULL
0	NULL
T	NULL
®	NULL
c	NULL
5	NULL
{	NULL
~	NULL
o	NULL
3	NULL
o	NULL
§	NULL
{	NULL
LL	NULL
G	NULL
J	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
1.0	NULL
25	NULL
5	NULL
,	NULL
10	NULL
25	NULL
50	NULL
100	NULL
,	NULL
TPCK	NULL
(	NULL
uM	NULL
)	NULL
TLCK	NULL
(	NULL
M	NULL
)	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS-induced	NULL
TF	NULL
gene	NULL
transcription	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Panel	NULL
a	NULL
,	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
and	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
were	NULL
transfected	NULL
into	NULL
THP-1	NULL
cells	NULL
using	NULL
DEAE-dextran	NULL
.	NULL

After	NULL
46	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
four	NULL
equal	NULL
portions	NULL
which	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
control	NULL
,	NULL
C	NULL
)	NULL
or	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
5	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
(	NULL
light	NULL
units	NULL
)	NULL
was	NULL
measured	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
to	NULL
determine	NULL
-fold	NULL
inductions	NULL
+	NULL
standard	NULL
experimental	NULL
mean	NULL
(	NULL
S.E	NULL
.	NULL
)	NULL

.	NULL

Luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
was	NULL
induced	NULL
6.2	NULL
+	NULL
2.5-fold	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
was	NULL
induced	NULL
54.5	NULL
+	NULL
16-fold	NULL
.	NULL

Luciferase	NULL
activity	NULL
expressed	NULL
by	NULL
control	NULL
samples	NULL
was	NULL
7205	NULL
+	NULL
1289	NULL
for	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
and	NULL
12941	NULL
+	NULL
1849	NULL
for	NULL
p	NULL
(	NULL
TF	NULL
)	NULL
,	NULL
SVLUC	NULL
.	NULL

Panel	NULL
b	NULL
,	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
pTF	NULL
(	NULL
-278	NULL
)	NULL
LUC	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LPS	NULL
or	NULL
with	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
0.1	NULL
,	NULL
1.0	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
5.0	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
and	NULL
100	NULL
um	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
5	NULL
h.	NULL
The	NULL
mean	NULL
-fold	NULL
induction	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
above	NULL
.	NULL

LPS	NULL
induced	NULL
luciferase	NULL
expression	NULL
5.9	NULL
+	NULL
2.8-fold	NULL
.	NULL

gene	NULL
encodes	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
can	NULL
be	NULL
measured	NULL
using	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

PMA	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
pretreating	NULL
the	NULL
cells	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
EGR-1	NULL
complex	NULL
was	NULL
characterized	NULL
by	NULL
competition	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
an	NULL
EGR-1	NULL
site	NULL
or	NULL
an	NULL
AP-1	NULL
site	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
radiolabeled	NULL
oligonucleotide	NULL
also	NULL
bound	NULL
Sp1	NULL
,	NULL
which	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
PMA	NULL
induction	NULL
of	NULL
EGR-1	NULL
mRNA	NULL
was	NULL
not	NULL
prevented	NULL
by	NULL
TPCK	NULL
or	NULL
TLCK	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
TPCK	NULL
and	NULL
TLCK	NULL
were	NULL
not	NULL
general	NULL
inhibitors	NULL
of	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
demonstrated	NULL
that	NULL
the	NULL
protease	NULL
inhibitors	NULL
TPCK	NULL
and	NULL
TLCK	NULL
reduced	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

TPCK	NULL
was	NULL
a	NULL
more	NULL
potent	NULL
inhibitor	NULL
than	NULL
the	NULL
structurally	NULL
related	NULL
inhibitor	NULL
,	NULL
TLCK	NULL
.	NULL

Inhibition	NULL
of	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
a	NULL
Monocytes	NULL
THP-1	NULL
r	NULL
--	NULL
--	NULL
-4	NULL
-	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-4	NULL
TLCK	NULL
=-	NULL
-	NULL
-	NULL
+	NULL
#	NULL
m	NULL
(	NULL
m	NULL
cp	NULL
TPCK	NULL
-	NULL
-	NULL
+	NULL
-	NULL
e	NULL
2	NULL
LPS	NULL
-	NULL
++	NULL
+	NULL
~	NULL
+	NULL
+	NULL
+	NULL
c-Rel/p65	NULL
-	NULL
»	NULL
7	NULL
b	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
8	NULL
TLCK	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
10100	NULL
TPCK	NULL
(	NULL
uM	NULL
)	NULL
-	NULL
-	NULL
1	NULL
5	NULL
10	NULL
-	NULL
LPS	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
c-Rel/p65	NULL
>	NULL
¥e	NULL
#	NULL
hes	NULL
Gel	NULL
Shift	NULL
n	NULL
kD	NULL
-	NULL
98	NULL
-	NULL
64	NULL
50	NULL
IxBor	NULL
-	NULL
>	NULL
>	NULL
-	NULL
sink	NULL
ane	NULL
tp	NULL
auth	NULL
<	NULL
+	NULL
Ah	NULL
St	NULL
Western	NULL
-	NULL
30	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Inhibition	NULL
of	NULL
LPS	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Panel	NULL
a	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
or	NULL
THP-1	NULL
cells	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
1	NULL
or	NULL
10	NULL
ug/ml	NULL
of	NULL
LPS	NULL
,	NULL
respectively	NULL
,	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
was	NULL
determined	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
kB-like	NULL
site	NULL
from	NULL
the	NULL
TF	NULL
promoter	NULL
(	NULL
19	NULL
)	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
activated	NULL
c-Rel/p65	NULL
heterodimers	NULL
(	NULL
arrow	NULL
)	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
band	NULL
observed	NULL
in	NULL
all	NULL
lanes	NULL
represents	NULL
nonspecific	NULL
protein	NULL
binding	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
c-Rel/p65	NULL
complex	NULL
from	NULL
monocytes	NULL
is	NULL
partially	NULL
degraded	NULL
by	NULL
proteolysis	NULL
during	NULL
the	NULL
isolation	NULL
pro-cedure	NULL
,	NULL
despite	NULL
the	NULL
use	NULL
of	NULL
protease	NULL
inhibitors	NULL
.	NULL

Panel	NULL
b	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
TPCK	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
10	NULL
and	NULL
100	NULL
um	NULL
)	NULL
before	NULL
addition	NULL
of	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
Activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
was	NULL
determined	NULL
by	NULL
EMSA	NULL
as	NULL
above	NULL
.	NULL

IxBa	NULL
protein	NULL
in	NULL
parallel	NULL
cytosolic	NULL
extracts	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
that	NULL
resulted	NULL
in	NULL
decreased	NULL
IxBa	NULL
protein	NULL
in	NULL
cytosolic	NULL
extracts	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

LPS-induced	NULL
TF	NULL
expression	NULL
was	NULL
abolished	NULL
by	NULL
10	NULL
um	NULL
TPCK	NULL
and	NULL
only	NULL
slightly	NULL
reduced	NULL
by	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
TLCK	NULL
.	NULL

However	NULL
,	NULL
100	NULL
um	NULL
TLCK	NULL
abolished	NULL
induced	NULL
TF	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
relative	NULL
potency	NULL
of	NULL
these	NULL
inhibitors	NULL
reported	NULL
for	NULL
blocking	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
monocytic	NULL
cells	NULL
was	NULL
prevented	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
at	NULL
concentrations	NULL
that	NULL
blocked	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
,	NULL
suggesting	NULL
that	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
was	NULL
regulated	NULL
by	NULL
IxBa	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IxBa	NULL
can	NULL
bind	NULL
to	NULL
either	NULL
p65	NULL
or	NULL
c-Rel	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicated	NULL
that	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
was	NULL
required	NULL
for	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
cells	NULL
leads	NULL
to	NULL
a	NULL
transient	NULL
loss	NULL
of	NULL
IxBa	NULL
«	NULL
protein	NULL
,	NULL
indicating	NULL
that	NULL
activation	NULL
of	NULL
NF-kB/Rel	NULL
proteins	NULL
re	NULL
Inhibition	NULL
of	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
AB	NULL
.	NULL

-	NULL
~-	NULL
~~	NULL
-	NULL
oE	NULL
cAZoS	NULL
Comp	NULL
.	NULL

-	NULL
-	NULL
-	NULL
-	NULL
E	NULL
A	NULL
-	NULL
-	NULL
TLCK	NULL
\-	NULL
-o-	NULL
o	NULL
-	NULL
-	NULL
-	NULL
--	NULL
TPCK	NULL
=-	NULL
-o	NULL
4	NULL
-o	NULL
-	NULL
-	NULL
-	NULL
--	NULL
PMA	NULL
-	NULL
+	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
incubated	NULL
with	NULL
PMA	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a	NULL
30-min	NULL
pretreatment	NULL
with	NULL
TPCK	NULL
(	NULL
10	NULL
um	NULL
)	NULL
or	NULL
TLCK	NULL
(	NULL
100	NULL
um	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
EGR-1	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
EMSA	NULL
.	NULL

Sp1	NULL
also	NULL
bound	NULL
to	NULL
this	NULL
radiolabeled	NULL
oligonucleotide	NULL
.	NULL

Competition	NULL
studies	NULL
used	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
an	NULL
EGR-1	NULL
site	NULL
(	NULL
E	NULL
)	NULL
or	NULL
an	NULL
AP-1	NULL
site	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
EGR-1	NULL
complex	NULL
also	NULL
was	NULL
analyzed	NULL
using	NULL
antisera	NULL
(	NULL
5	NULL
ul	NULL
)	NULL
against	NULL
EGR-1	NULL
(	NULL
a-E	NULL
)	NULL
,	NULL
AP-2	NULL
(	NULL
«	NULL
-A2	NULL
)	NULL
,	NULL
or	NULL
Spl	NULL
(	NULL
«	NULL
-S	NULL
)	NULL
.	NULL

quires	NULL
release	NULL
and	NULL
subsequent	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
22	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
protease	NULL
inhibitors	NULL
prevent	NULL
loss	NULL
of	NULL
IxBa	NULL
and	NULL
block	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
studies	NULL
did	NULL
not	NULL
investigate	NULL
if	NULL
TPCK	NULL
also	NULL
blocked	NULL
LPS-induced	NULL
gene	NULL
expression	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
TPCK	NULL
was	NULL
shown	NULL
to	NULL
prevent	NULL
LPS	NULL
induction	NULL
of	NULL
IkxBa	NULL
mRNA	NULL
in	NULL
70	NULL
%	NULL
/3	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
authors	NULL
argued	NULL
that	NULL
TPCK	NULL
was	NULL
not	NULL
a	NULL
general	NULL
inhibitor	NULL
of	NULL
transcription	NULL
because	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
long-lived	NULL
glyceraldehyde	NULL
phosphodehydrogenase	NULL
mRNA	NULL
were	NULL
unchanged	NULL
.	NULL

Similar	NULL
data	NULL
was	NULL
noted	NULL
with	NULL
the	NULL
short-lived	NULL
c-fos	NULL
mRNA	NULL
,	NULL
although	NULL
this	NULL
data	NULL
was	NULL
not	NULL
shown	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
specificity	NULL
of	NULL
inhibition	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
was	NULL
shown	NULL
by	NULL
analyzing	NULL
PMA	NULL
induction	NULL
of	NULL
EGR-1	NULL
expression	NULL
in	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

These	NULL
protease	NULL
inhibitors	NULL
did	NULL
not	NULL
block	NULL
induction	NULL
of	NULL
EGR-1	NULL
protein	NULL
or	NULL
mRNA	NULL
expression	NULL
at	NULL
concentrations	NULL
that	NULL
abolished	NULL
LPS	NULL
induction	NULL
of	NULL
TF	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
TPCK	NULL
and	NULL
TLCK	NULL
specifically	NULL
inhibited	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
and	NULL
were	NULL
not	NULL
general	NULL
inhibitors	NULL
of	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Exposure	NULL
of	NULL
monocytic	NULL
cells	NULL
to	NULL
LPS	NULL
stimulates	NULL
the	NULL
rapid	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
regulate	NULL
expression	NULL
of	NULL
many	NULL
primary	NULL
response	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
the	NULL
cytokines	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
and	NULL
IL-6	NULL
,	NULL
and	NULL
those	NULL
encoding	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
proteins	NULL
them-selves	NULL
,	NULL
such	NULL
as	NULL
p50	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
IxBa	NULL
(	NULL
34	NULL
)	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

These	NULL
genes	NULL
contain	NULL
«	NULL
B	NULL
sites	NULL
that	NULL
match	NULL
the	NULL
established	NULL
consensus	NULL
sequence	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
«	NULL
B-like	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
TF	NULL
and	NULL
IL-8	NULL
promoters	NULL
do	NULL
not	NULL
match	NULL
this	NULL
consensus	NULL
sequence	NULL
.	NULL

They	NULL
fail	NULL
to	NULL
bind	NULL
prototypic	NULL
p50/p65	NULL
heterodimers	NULL
and	NULL
instead	NULL
bind	NULL
c-Rel/p65	NULL
heterodimers	NULL
(	NULL
19	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
is	NULL
a	NULL
subset	NULL
of	NULL
inducible	NULL
genes	NULL
expressed	NULL
by	NULL
monocytes	NULL
that	NULL
are	NULL
regulated	NULL
by	NULL
c-Rel/p65	NULL
heterodimers	NULL
.	NULL

Binding	NULL
of	NULL
different	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
family	NULL
to	NULL
distinct	NULL
classes	NULL
of	NULL
kB	NULL
and	NULL
«	NULL
B-like	NULL
sites	NULL
represents	NULL
an	NULL
important	NULL
mechanism	NULL
for	NULL
selective	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
septic	NULL
shock	NULL
,	NULL
monocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
are	NULL
the	NULL
only	NULL
cell	NULL
types	NULL
within	NULL
the	NULL
vasculature	NULL
that	NULL
express	NULL
TF	NULL
(	NULL
35-38	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
our	NULL
laboratory	NULL
showed	NULL
that	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
also	NULL
is	NULL
required	NULL
for	NULL
LPS	NULL
and	NULL
cytokine	NULL
induction	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
inducible	NULL
TF	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
is	NULL
26367	NULL
blocked	NULL
by	NULL
TPCK	NULL
and	NULL
TLCK	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
in	NULL
monocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
controlled	NULL
by	NULL
a	NULL
common	NULL
regulatory	NULL
mechanism	NULL
.	NULL

Specific	NULL
inhibitors	NULL
that	NULL
prevent	NULL
activation	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
in	NULL
these	NULL
two	NULL
cell	NULL
types	NULL
in	NULL
vivo	NULL
may	NULL
represent	NULL
novel	NULL
antithrom-botic	NULL
drugs	NULL
for	NULL
use	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
thrombotic	NULL
disorders	NULL
.	NULL

Acknowledgments-I	NULL
acknowledge	NULL
H.	NULL
Larson	NULL
,	NULL
P.	NULL
Oeth	NULL
,	NULL
and	NULL
P.	NULL
Nantermet	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
,	NULL
D.	NULL
Nielsen	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
S.	NULL
Steinemann	NULL
for	NULL
help	NULL
with	NULL
the	NULL
FACS	NULL
analysis	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
for	NULL
IxBa	NULL
antiserum	NULL
,	NULL
and	NULL
G.	NULL
Parry	NULL
and	NULL
L.	NULL
Curtiss	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Edgington	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ruf	NULL
,	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Thromb	NULL
.	NULL

Hae-most	NULL
.	NULL

66	NULL
,	NULL
67-79	NULL
2	NULL
.	NULL

Taylor	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
Jr.	NULL
,	NULL
Chang	NULL
,	NULL
A.	NULL
,	NULL
Ruf	NULL
,	NULL
W.	NULL
,	NULL
Morrissey	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Hinshaw	NULL
,	NULL
L.	NULL
,	NULL
Catlett	NULL
,	NULL
R.	NULL
,	NULL
Blick	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cire	NULL
.	NULL

Shock	NULL
83	NULL
,	NULL
127-134	NULL
3	NULL
.	NULL

Warr	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Rao	NULL
,	NULL
L.	NULL
V.	NULL
M.	NULL
,	NULL
and	NULL
Rapaport	NULL
,	NULL
S.	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
1481-1489	NULL
4	NULL
.	NULL

Levi	NULL
,	NULL
M.	NULL
,	NULL
ten	NULL
Cate	NULL
,	NULL
H.	NULL
,	NULL
Bauer	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
van	NULL
der	NULL
Poll	NULL
,	NULL
T.	NULL
,	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Biller	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
van	NULL
Deventer	NULL
,	NULL
S.	NULL
J.	NULL
H.	NULL
,	NULL
Hack	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Wouter	NULL
ten	NULL
Cate	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Rosen-berg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

93	NULL
,	NULL
114-120	NULL
5	NULL
.	NULL

Okajima	NULL
,	NULL
K.	NULL
,	NULL
Yang	NULL
,	NULL
W.-P.	NULL
,	NULL
Okabe	NULL
,	NULL
H.	NULL
,	NULL
Inoue	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Takatsuki	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Hematol	NULL
.	NULL

36	NULL
,	NULL
265-271	NULL
6	NULL
.	NULL

Gregory	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Morrissey	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
2752-2755	NULL
7	NULL
.	NULL

Brand	NULL
,	NULL
K.	NULL
,	NULL
Fowler	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4732-4738	NULL
8	NULL
.	NULL

Crutchley	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Hirsh	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
382-386	NULL
9	NULL
.	NULL

Crutchley	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Solomon	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Conanan	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

12	NULL
,	NULL
664-670	NULL
10	NULL
.	NULL

Ollivier	NULL
,	NULL
V.	NULL
,	NULL
Houssaye	NULL
,	NULL
S.	NULL
,	NULL
Ternisien	NULL
,	NULL
C.	NULL
,	NULL
Léon	NULL
,	NULL
A.	NULL
,	NULL
de	NULL
Verneuil	NULL
,	NULL
H.	NULL
,	NULL
Elbim	NULL
,	NULL
C.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
973-979	NULL
11.	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
,	NULL
Ollivier	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Hakim	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

38	NULL
,	NULL
562-566	NULL
12	NULL
.	NULL

Ollivier	NULL
,	NULL
V.	NULL
,	NULL
Ternisien	NULL
,	NULL
C.	NULL
,	NULL
Vu	NULL
,	NULL
T.	NULL
,	NULL
Hakim	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

322	NULL
,	NULL
231-234	NULL
13	NULL
.	NULL

Herbert	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Savi	NULL
,	NULL
P.	NULL
,	NULL
Laplace	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
Lale	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

310	NULL
,	NULL
31-33	NULL
14	NULL
.	NULL

Herbert	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Savi	NULL
,	NULL
P.	NULL
,	NULL
Laplace	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Lale	NULL
,	NULL
A.	NULL
,	NULL
Dol	NULL
,	NULL
F.	NULL
,	NULL
Dumas	NULL
,	NULL
A.	NULL
,	NULL
Labit	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Minty	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

328	NULL
,	NULL
268-270	NULL
15	NULL
.	NULL

Ramani	NULL
,	NULL
M.	NULL
,	NULL
Ollivier	NULL
,	NULL
V.	NULL
,	NULL
Ternisien	NULL
,	NULL
C.	NULL
,	NULL
Vu	NULL
,	NULL
T.	NULL
,	NULL
Elbim	NULL
,	NULL
C.	NULL
,	NULL
Hakim	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Br	NULL
:	NULL
J.	NULL
Haematol	NULL
.	NULL

85	NULL
,	NULL
462-468	NULL
16	NULL
.	NULL

Pradier	NULL
,	NULL
O.	NULL
,	NULL
Gérard	NULL
,	NULL
C.	NULL
,	NULL
Delvaux	NULL
,	NULL
A.	NULL
,	NULL
Lybin	NULL
,	NULL
M.	NULL
,	NULL
Abramowicz	NULL
,	NULL
D.	NULL
,	NULL
Capel	NULL
,	NULL
P.	NULL
,	NULL
Velu	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Goldman	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23	NULL
,	NULL
2700-2703	NULL
17	NULL
.	NULL

Ramani	NULL
,	NULL
M.	NULL
,	NULL
Ollivier	NULL
,	NULL
V.	NULL
,	NULL
Khechai	NULL
,	NULL
F.	NULL
,	NULL
Vu	NULL
,	NULL
T.	NULL
,	NULL
Ternisien	NULL
,	NULL
C.	NULL
,	NULL
Bridey	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
de	NULL
Prost	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

334	NULL
,	NULL
114-116	NULL
18	NULL
.	NULL

Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
19	NULL
.	NULL

Oeth	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
3772-3781	NULL
20	NULL
.	NULL

Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immu-nobiology	NULL
187	NULL
,	NULL
233-256	NULL
21	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2064-2070	NULL
22	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11803-11810	NULL
23	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Nerlah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
182-185	NULL
24	NULL
.	NULL

Morrissey	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Fair	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Thromb	NULL
.	NULL

Res	NULL
.	NULL

52	NULL
,	NULL
247-261	NULL
25	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
26	NULL
.	NULL

Virca	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Northemann	NULL
,	NULL
W.	NULL
,	NULL
Shiels	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Widera	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Broome	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
BioTechniques	NULL
8	NULL
,	NULL
370-371	NULL
27	NULL
.	NULL

Morrissey	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Fakhrai	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
129-135	NULL
28	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1912-1915	NULL
29	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Hass	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
571-577	NULL
30	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1899-1913	NULL
31	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Ernst	NULL
,	NULL
M.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4685-4695	NULL
32	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
V.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
3301-3310	NULL
33	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
28-32	NULL
34	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Schmidt-Ullrich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
5043-5049	NULL
35	NULL
.	NULL

Almdahl	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
Osterud	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Thromb	NULL
.	NULL

Res	NULL
.	NULL

47	NULL
,	NULL
37-46	NULL
36	NULL
.	NULL

Andersen	NULL
,	NULL
O.	NULL
K.	NULL
,	NULL
Osterud	NULL
,	NULL
B.	NULL
,	NULL
Gaudernack	NULL
,	NULL
G.	NULL
,	NULL
Lundgren	NULL
,	NULL
T.-L.	NULL
,	NULL
and	NULL
Giercksky	NULL
,	NULL
K.-E.	NULL
(	NULL
1985	NULL
)	NULL
Acta	NULL
Chir	NULL
.	NULL

Scand	NULL
.	NULL

151	NULL
,	NULL
205-211	NULL
37	NULL
.	NULL

Niemetz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1972	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

51	NULL
,	NULL
307-313	NULL
38	NULL
.	NULL

Drake	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Cheng	NULL
,	NULL
J.	NULL
,	NULL
Chang	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Taylor	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

142	NULL
,	NULL
1-13	NULL
39	NULL
.	NULL

Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

8	NULL
,	NULL
5902a	NULL

